MRA Advisory Group: AVAV position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MRA Advisory Group on AVAV, newest first. How the timeline and the estimate are built.
MRA Advisory Group held 0 AVAV shares at 2026-09-30 per its 13F-HR filed 2026-10-07.
the latest 13F is the newest step
- period ended2026-09-3013F 0 sharesChange vs previous 13F -1,000 shares
13F-HR 0001841816-26-000007 filed by MRA Advisory Group
Accepted , ingestedExited: the 13F for this period no longer lists the position.
- period ended2026-06-3013F 1,000 sharesChange vs previous 13F 0 shares
0.06% of the 13F portfolio, value $165,070.
13F-HR 0001841816-26-000003 filed by MRA Advisory Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 1,000 sharesChange vs previous 13F 0 shares
0.07% of the 13F portfolio, value $183,050.
13F-HR 0001841816-26-000002 filed by MRA Advisory Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,000 sharesChange vs previous 13F 0 shares
0.1% of the 13F portfolio, value $241,890.
13F-HR 0001841816-26-000001 filed by MRA Advisory Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,000 sharesChange vs previous 13F 0 shares
0.14% of the 13F portfolio, value $314,890.
13F-HR 0001841816-25-000005 filed by MRA Advisory Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,000 sharesChange vs previous 13F not available
0.13% of the 13F portfolio, value $284,950.
13F-HR 0001841816-25-000003 filed by MRA Advisory Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).